Simultaneous determination of ginsenoside (G-Re, G-Rg1, G-Rg2, G-F1, G-Rh1) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 15;879(22):2011-7. doi: 10.1016/j.jchromb.2011.05.018. Epub 2011 May 23.

Abstract

Ginsenoside Re (G-Re) improved the memory function of experimental animals in a preclinical study. Several types of saponins including G-Rg1, G-Rg2, G-F1, G-Rh1, and protopanaxatriol (PPT) may be the metabolites of G-Re according to reports from preclinical trials. In order to support a study of the pharmacokinetics of G-Re, an analytical method for G-Re and the co-detection of its probable metabolites using liquid chromatography tandem mass spectrometry (LC-MS/MS) was developed and validated. Solid phase extraction was utilized in the sample preparation. Separation of the analytes was achieved using a gradient elution (0.05% formic acid-methanol-acetonitrile, each organic phase containing 0.05% formic acid) at a flow rate of 0.3 mL/min with a retention time of approximately 2.88 min for G-Re. Data were acquired in the multiple reaction mode (MRM) and the linear range of the standard curve of plasma and urine samples for G-Re was 0.05-20 ng/mL with r(2)≥0.99. In the analysis of probable metabolites, G-Re, G-Rg1, G-F1, G-Rh1 and PPT were all detected in samples; however, G-Rg2 was not detected.

MeSH terms

  • Chromatography, Liquid / methods*
  • Drug Stability
  • Ginsenosides / blood*
  • Ginsenosides / metabolism
  • Ginsenosides / pharmacokinetics
  • Ginsenosides / urine*
  • Humans
  • Linear Models
  • Reproducibility of Results
  • Sapogenins / blood*
  • Sapogenins / metabolism
  • Sapogenins / pharmacokinetics
  • Sapogenins / urine*
  • Sensitivity and Specificity
  • Solid Phase Extraction
  • Tandem Mass Spectrometry / methods*

Substances

  • Ginsenosides
  • Sapogenins
  • protopanaxatriol